Lisle Nabell
- Oncology top 10%
- Otorhinolaryngology top 2%
- Molecular Biology
- Surgery
- Pulmonary and Respiratory Medicine
- Co-authors
- Adam S. GardenJay S. CooperEverett E. VokesE.M. HorwitzJonathan HarrisElizabeth GoreB.S. GlissonArlene A. Forastiere
- Topics
- Advanced Breast Cancer Therapies (8 papers)Cancer Treatment and Pharmacology (8 papers)Breast Cancer Treatment Studies (6 papers)
- Journals
- Journal of Clinical OncologyCancer ResearchInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Lisle Nabell
24 papers receiving 458 citations
Peers
Comparison fields: 5 of 56
- Oncology 244
- Otorhinolaryngology 157
- Molecular Biology 152
- Surgery 115
- Pulmonary and Respiratory Medicine 89
Countries citing papers authored by Lisle Nabell
This map shows the geographic impact of Lisle Nabell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisle Nabell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisle Nabell more than expected).
Fields of papers citing papers by Lisle Nabell
This network shows the impact of papers produced by Lisle Nabell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisle Nabell. The network helps show where Lisle Nabell may publish in the future.
Co-authorship network of co-authors of Lisle Nabell
This figure shows the co-authorship network connecting the top 25 collaborators of Lisle Nabell. A scholar is included among the top collaborators of Lisle Nabell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisle Nabell. Lisle Nabell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 19 | |
| 5 | 12 | |
| 6 | 50 | |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 0 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | 10 | |
| 14 | 2 | |
| 15 | Clinical aspects of a phase I study of PD-0325901, a selective oral MEK inhibitor, in patients with advanced cancer | 13 |
| 16 | 1 | |
| 17 | 2 | |
| 18 | 21 | |
| 19 | 68 | |
| 20 | 147 |
About Lisle Nabell
Lisle Nabell is a scholar working on Otorhinolaryngology, Oncology and Cancer Research, having authored 25 papers that have together received 481 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (8 papers), Cancer Treatment and Pharmacology (8 papers) and Breast Cancer Treatment Studies (6 papers). The work is most often cited by research in Otorhinolaryngology (157 citations), Oncology (244 citations) and Dermatology (48 citations). Lisle Nabell has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Adam S. Garden, Jay S. Cooper, Everett E. Vokes, E.M. Horwitz, Jonathan Harris, Elizabeth Gore, B.S. Glisson, Arlene A. Forastiere, John A. Ridge and Christopher U. Jones. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.